NGNE
Neurogene Inc
31.30$
+0.0%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.1% | -54.5% | +128.2% | – | – | – | – | – | +435.6% | -48.0% | +237.9% | +3.0% | -1.5% | -4.8% | |
| – | – | – | – | – | – | – | – | – | – | – | +39.7% | +13.3% | +486.7% | +70.5% | |
| – | -110.9% | – | +233.7% | -115.2% | – | -80.5% | -692.3% | – | – | +65.1% | -269.0% | – | – | – | |
| – | -89.7% | +82.2% | +869.6% | -76.3% | +2,540.8% | -30.7% | -90.1% | +1,693.9% | +152.4% | +727.8% | -87.9% | -85.6% | +151.7% | +46.4% | |
| – | -89.7% | +40,857.4% | +792.8% | +101.6% | +1.1% | – | -12.6% | -101.2% | +222.5% | +727.8% | -87.9% | – | -588.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | +2,800.0% | +79.3% | +17.3% | |
| – | – | – | +131.2% | +105.3% | -23.5% | -99.4% | +34.8% | +14,327.5% | -6.2% | -33.8% | +30.3% | +39.0% | +99.0% | -83.5% | |
| – | – | – | – | – | – | – | +26.2% | +165.8% | -25.2% | -127.7% | – | +481.1% | -117.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.